A research team has developed an innovative biomimetic dual-mode magnetic resonance imaging (MRI) nanoprobe for detecting early-stage liver fibrosis in non-alcoholic fatty liver disease (NAFLD). The ...
A multicenter study shows that a hybrid model combining MRI radiomics, delta features, and clinical variables predicts ...
New findings from the DIRECT PLUS, 18-month-long lifestyle intervention trial underscores the potential to observe and signify alterations of MRI-assessed liver fat with proteomics according to new ...
The FDA declined to approve Orviglance for MRI liver imaging in patients with severe kidney impairment, requesting additional clinical data. The FDA has issued a complete response letter for the new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results